These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23324271)

  • 1. Relationship of RhoA signaling activity with ezrin expression and its significance in the prognosis for breast cancer patients.
    Ma L; Liu YP; Zhang XH; Geng CZ; Li ZH
    Chin Med J (Engl); 2013 Jan; 126(2):242-7. PubMed ID: 23324271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
    DiGiovanna MP; Stern DF; Edgerton SM; Whalen SG; Moore D; Thor AD
    J Clin Oncol; 2005 Feb; 23(6):1152-60. PubMed ID: 15718311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of RhoA signaling transduction on expression of Ezrin in breast cancer cell lines.
    Ma L; Liu YP; Zhang XH; Xing LX; Wang JL; Geng CZ
    Ai Zheng; 2009 Feb; 28(2):108-11. PubMed ID: 19550117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.
    Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C
    Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation.
    Wang C; Tran-Thanh D; Moreno JC; Cawthorn TR; Jacks LM; Wang DY; McCready DR; Done SJ
    Breast Cancer Res Treat; 2011 Sep; 129(2):373-86. PubMed ID: 21046228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma.
    Cui Y; Li T; Zhang D; Han J
    Cancer Invest; 2010 Mar; 28(3):242-7. PubMed ID: 20158339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.
    Zhang L; Teng Y; Zhang Y; Liu J; Xu L; Qu J; Hou K; Yang X; Liu Y; Qu X
    J Clin Pathol; 2012 Jan; 65(1):36-40. PubMed ID: 22049226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
    Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
    Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.
    Elliott BE; Meens JA; SenGupta SK; Louvard D; Arpin M
    Breast Cancer Res; 2005; 7(3):R365-73. PubMed ID: 15987432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
    Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease.
    Bellizzi A; Mangia A; Chiriatti A; Petroni S; Quaranta M; Schittulli F; Malfettone A; Cardone RA; Paradiso A; Reshkin SJ
    Int J Mol Med; 2008 Jul; 22(1):25-31. PubMed ID: 18575772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
    Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
    Sizemore S; Cicek M; Sizemore N; Ng KP; Casey G
    Cancer Res; 2007 Jul; 67(13):6183-91. PubMed ID: 17616675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
    Esteva FJ; Sahin AA; Smith TL; Yang Y; Pusztai L; Nahta R; Buchholz TA; Buzdar AU; Hortobagyi GN; Bacus SS
    Cancer; 2004 Feb; 100(3):499-506. PubMed ID: 14745865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and phosphorylation of ezrin and merlin in human pancreatic cancer.
    Zhou J; Feng Y; Tao K; Su Z; Yu X; Zheng J; Zhang L; Yang D
    Int J Oncol; 2014 Jun; 44(6):2059-67. PubMed ID: 24728215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
    Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
    J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of ezrin in non--small-cell lung cancer.
    Zhang XQ; Chen GP; Wu T; Yan JP; Zhou JY
    Clin Lung Cancer; 2012 May; 13(3):196-204. PubMed ID: 22137559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
    Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical ezrin localization as a marker of locally advanced breast cancer.
    Arslan AA; Silvera D; Arju R; Giashuddin S; Belitskaya-Levy I; Formenti SC; Schneider RJ
    Breast Cancer Res Treat; 2012 Aug; 134(3):981-8. PubMed ID: 22415480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.